Comments
Pharma major Hetero will be investing ₹1,000 crore expansion of its existing facility in Andhra Pradesh.
“We have the largest manufacturing plant in the State and 40 per cent of global HIV drugs are manufactured there. We will invest ₹1,000 cr more over next two years which will create 3,000 jobs,” Vamsi Krishna Bandi Managing Director, Hetero, said at AP Global Investors Summit 2023 here on Saturday.
Hetero group is a $2.5-billion enterprise engaged in pharmaceutical products globally.
“Hetero is one of the beneficiaries of the AP government pharmaceutical policy,” Bandi said.
Hetero has the largest manufacturing campus spread across 500 acres in Nakapalli Vishakhapatnam.
Dr Reddy’s
Referring to the large presence of Dr Reddy’s in and around Visakhapatnam, K Satish Reddy, Chairman of Dr Reddy’s Laboratories said: “We continue to invest in Andhra Pradesh.”
The Indian pharma industry was now poised to take advantage of the China Plus model in the global supply chain and greater interest in services post Russia-Ukraine war, Reddy said.
Ecosystem
Satyanaryana Chava, Founder & CEO of Laurus Labs said the State has a good ecosystem, and setting up of more industrial parks would attract more pharma companies.
Stating that the State was already a hub for APIs production with the presence of major companies including Laurus Labs, Chava said: “ We are committed to investing more in the pharma sector in Andhra Pradesh. “
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.